BACKGROUND: A 3-dimensional hyperboloid model has been proposed to characterize ventricular tachycardia (VT) circuitry. We ...

The healthcare sector inched up just 0.1% at midday Tuesday, with all other sectors on the Australian bourse trading in the ...

Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

The ASX 200 has reset to levels seen over a month ago, falling on broad weakness across sectors as the RBA remains hawkish on ...

The All Ordinaries Index (ASX: XAO) is sliding today, but don’t blame this rocketing ASX All Ords healthcare share. Here’s ...

The sudden death of former TV actor Zhen Zhiqiang at the age of 59 has raised alarming questions about the risks of cardiac arrest during or after exercise. This tragic incident highlights a critical ...

Despite the S&P/ASX 200 Index dipping, Domino's is on the rise with takeover rumors swirling, DroneShield is climbing on a big new contract, and Imricor is making waves with a breakthrough medical ...

LIKE most kids, Ella-May loved Halloween – so when she suddenly started acting oddly one October evening, her mum assumed it ...

Adagio intends to use the proceeds to support the FULCRUM-VT clinical study assessing its vCLAS ULTC System. The study, which ...

Michael Fraley breaks down what paramedics need to know about what’s changed — and what hasn’t — in the new resuscitation ...

Solid Biosciences ( ($SLDB) ) has released its Q3 earnings. Here is a breakdown of the information Solid Biosciences presented to its investors.